Login To Trade  |  About IIFL
  • NIFTY  7971.3  -30.65 -0.38%
  • SENSEX 26283.09  -109.29 -0.41%
  1. General
  2. Others

  3. Others

Dr. Reddy’s Laboratories launches Olanzapine Tablets

India Infoline News Service | Mumbai | April 25, 2012 08:36 IST

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Laboratories announced today that it has launched Olanzapine Tablets (2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg), a bioequivalent generic version of ZYPREXA Tablets in the US market on April 23, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Olanzapine Tablets.

Dr. Reddy’s Olanzapine Tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the U.S. on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries Ltd.

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Olanzapine Tablets in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths are available in 30 and 500 count bottles.

BSE 4,310.15 131.45 (3.15%)
NSE 4,302.65 121.90 (2.92%)

***Note: This is a NSE Chart


Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!

Read more on: Dr.  Reddy’s  Laboratories 
article
113103103819
Dr. Reddy’s Laboratories launches Olanzapine Tablets
Dr. Reddy’s Laboratories launches Olanzapine Tablets
The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.
http://www.indiainfoline.com/article/news-top-story/dr-reddy’s-laboratories-launches-olanzapine-tablets-113103103819_1.html
April 25, 2012 08:36 IST
http://content.indiainfoline.com/_media/iifl/img/article/old/full/1718993566_LS_drreddylab
Dr. Reddy’s Laboratories
Others
$rawVideoFileUrl$
$videoPlayerUrl$
News
Recent Reports

Stability in US and Europe to aid export growth

India Infoline Research Team / 10:47, Aug 24, 2015

In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.